Predictive Role of Serum Tumor Markers in Diagnosis of Pulmonary Tuberculosis
-
Jingjing MA
,
Dan XIA
,
Jing HU
,
Rui FU
,
Lijun XU
,
Ying ZHANG
,
Mengying ZHANG
,
Benhe LI
,
Jianghua YANG
,
Yufeng WEN
Abstract
Background: The diagnosis of pulmonary tuberculosis (PTB) is complicated and time-consuming currently. There was association of PTB with serum tumor markers. In this study we aimed to evaluate the predictive role of serum CA125, CA199 and CEA as diagnostic tools for PTB.
Methods: This study was designed as a case-control study with 565 subjects who visited the Yijishan Hospital from Jun to Dec in 2014.This case-control study matched as for age and sex with 113 cases and 452 controls. Serum CA125, CA199 and CEA levels were detected by electrochemiluminescence instrument. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was performed to evaluate the diagnostic value on PTB.
Results: Serum levels of CA125, CA199 and CEA in PTB patients were significantly higher than those in control group (P<0.001). There was no significantly different of three tumor markers between initial treatment group and retreatment group. The logistic regression analysis showed that CA125 was an impact factor to PTB. The ROC analysis revealed that AUC of CA125 was 0.966 (95%CI: 0.951-0.981), the sensitivity, specificity in serum and cut-off were 95.6%, 85.0% and 10.30 U/ml, respectively.
Conclusion: The serum CA125 has potential good diagnostic performance for PTB.
Maartens G, Wilkinson RJ (2007). Tuberculosis. Lancet, 370(9604):2030-43.
WHO (2014). Global Tuberculosis Report 2014. Available from: http://www.who.int/tb/pub-lications/global_report/en/.
Matsumoto K, Fukunaga Y, Monbayashi J, Arima K, Shimouchi A (2009). Investigation on" pa¬tient's de-lay" in TB detection. Kek¬kaku, 84 (7):523-9.
Srikanth P, Kamesh S, Daley P (2009). Bleach op-timization of sputum smear microscopy for pul-monary tuberculosis. Indian J Tuberc, 56 (4):174-84.
Ekinci GH, Karakaya E, Ongel EA, Hacio¬meroglu O, Yilmaz A (2014). Patient and Doc¬tor Delays in Smear-Negative and Smear-Posi¬tive Pulmonary Tuberculosis Patients Attend¬ing a Referral Hospital in Istanbul, Turkey. ScientificWorldJournal, 158186.
Burgess LJ, Swanepoel CG, Taljaard JJ (2001). The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis. Tuberculosis (Edinb), 81 (3):243-8.
Afrasiabian S, Mohsenpour B, Bagheri KH, Sigari N, Aftabi K (2013). Diagnostic value of serum adeno-sine deaminase level in pulmonary tuber¬culosis. J Res Med Sci, 18 (3):252-4.
Haldar S, Sankhyan N, Sharma N, Bansal A, Jain V, Gupta V, et al. (2012). Detection of Mycobacte¬rium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tu¬berculous meningitis in children. PloS One, 7 (9):e44630.
Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A (2010). Biomarkers and di-ag¬nostics for tuberculosis: progress, needs, and translation into practice. Lancet, 375 (9729):1920-37.
Wang Z, Tian YP (2014). Clinical value of serum tu-mor markers CA199, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma. Mol Clin Oncol, 2 (2):265-8.
He CZ, Zhang KH, Li Q, Liu XH, Hong Y, Lv NH (2013). Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroen¬terol, 13 (1):87.
Fernandez J, De Quiros B, Telenti M, Suarez Leiva P, Fernandez Llana B, Allende MT, Ruibal Morell A (1995). CA125 Serum levels in tubercolosis patients. Int J Biol Markers, 10 (3):180-1.
Sulaiman S, Tan KH (2009). Markedly-elevated se¬rum CA125 in a woman with pulmonary tu¬berculosis. Singapore Med J, 50 (1):e39-40.
Sekiya K, Sakai T, Homma S, Tojima H (2007). Pul-monary tuberculosis accompanied by a transient increase in serum carcinoembryonic antigen level with tuberculous empyema drain¬age. Intern Med, 46 (21):1795-8.
Racil H, Saad S, Rouhou SC, Chaouch N, Zarrouk M, Yaalaoui S, Chabbou A (2009). The value of tumor markers in pulmonary tuberculosis. Tunis Med, 87 (5):330-3.
Kim ES, Park KU, Song J, Lim HJ, Cho YJ, Yoon H, et al. (2013). The clinical significance of CA-125 in pulmonary tuberculosis. Tuberculosis (Edinb), 93 (2):222-6.
WHO (2013). Definitions and reporting framework for tuberculosis–2013 revision. Available from: http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf
Yin BW, Lloyd KO (2001). Molecular Cloning of the CA125 Ovarian Cancer Antigen Identifica¬tionasa New Mucin, MUC16. J Biol Chem, 276 (29):27371-5.
Nouwen EJ, Pollet DE, Eerdekens MW, Hen¬drix PG, Briers TW, De Broe ME (1986). Im-munohistochemical localization of placental alkaline phosphatase, carcinoembryonic anti¬gen, and can-cer antigen 125 in normal and ne¬oplastic human lung. Cancer Res, 46 (2):866-76.
Ronay G, J ger W, Tulusan A (1989). Immuno-histochemical and serologic detection of Ca-125 in patients with peritoneal tuberculosis and ascites. Geburtshilfe Frauenheilkd, 49 (1):61-3.
Ni XG, Bai XF, Mao YL, Shao Y, Wu J, Shan Y (2005). The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pan-creatic cancer. Eur J Surg Oncol, 31 (2):164-9.
Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Fernandez-del Castillo C, War¬shaw AL (2006). Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic ade-nocarcinoma. J Clin Oncol, 24 (18):2897-902.
Ishiura Y, Fujimura M, Minami S, Ueda A, Iwata M, Watanabe K, et al. (1996). Increased CA19-9 level in serum and bronchoalveolar lavage fluid from a pa-tient with pulmonary tuberculosis. Nihon Kyobu Shikkan Gakkai Zasshi, 34 (4):477-81.
Komiya T, Matsushima T, Kimura M, Adachi M (1994). A case of endobronchial tuberculosis with high serum CA19-9 and SLX level. Kek¬kaku, 69 (10):615-9.
Tasci C, Ozkaya S, Ozkara B, Tozkoparan E, Ozkan M, Karadurmus N, et al. (2012). The utility of tu-mor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis. Onco Targets Ther, 5:385-90.
Ichiki H, Shishido M, Nishitani K, Takatsugi K, Nishiyama S, Yano M, Watanabe K (1993). Evalua-tion of CEA, SLX and CA125 in active pulmo-nary tu¬berculosis. Nihon Kyobu Shikkan Gakkai Zasshi, 31 (12):1522-7.
Hamamoto Y, Koyama H, Hashihira M, Tanigu¬chi T, Hashimoto K, Osako T (1994). Clinical studies on nine cases with miliary tuberculosis: serum level of tumor markers and bronchos¬copy in differential diagnosis. Kekkaku, 69 (11):681-7.
| Files | ||
| Issue | Vol 45 No 4 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| CA125 CA199 CEA Pulmonary tuberculosis Receiver-operating Characteristic curve | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
